Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxence Ficheux

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 30, 2016
Pharmacokinetics of Intraperitoneal Daptomycin in Patients with Peritoneal Dialysis-Related PeritonitisLaure Peyro Saint Paul, Maxence Ficheux, Danièle Debruyne, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2023
Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokineticsLaure Peyro-Saint-Paul, Clémence Bechade, Alexandre Cesbron, et al.
BMJ Open|September 21, 2024
Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non-valvular atrial fibrillation: protocol for a prospective, randomised, open-label, blinded endpoint trial (APIDP2)Maxence Ficheux, Laure Peyro-Saint-Paul, Dorothée Balayn, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 30, 2016
Pharmacokinetics of Intraperitoneal Daptomycin in Patients with Peritoneal Dialysis-Related PeritonitisLaure Peyro Saint Paul, Maxence Ficheux, Danièle Debruyne, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2023
Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokineticsLaure Peyro-Saint-Paul, Clémence Bechade, Alexandre Cesbron, et al.
BMJ Open|September 21, 2024
Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non-valvular atrial fibrillation: protocol for a prospective, randomised, open-label, blinded endpoint trial (APIDP2)Maxence Ficheux, Laure Peyro-Saint-Paul, Dorothée Balayn, et al.
Pageof 7